An assessment of the US Presidential Emergency Plan for Aids Relief

2^nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

November 23-24, 2012 Hyderabad International Convention Centre, India

Anoop S. Pillai

Posters: Pharmaceut Reg Affairs

Abstract :

The President's Emergency Plan for AIDS Relief, also known as PEPFAR, is American Government initiative to combat the global HIV/AIDS epidemic. Since the HIV/AIDS epidemic began in the early 1980s, and it is not new to world but it is as lethal as always. Over 60 million people have been infected, which is equivalent to approximately 20 percent of the U.S. population, and nearly 30 million people have died of HIV-related causes (Census, 2011; UNAIDS). PEPFAR works for AIDS relief around the world but has a special focus on 15 countries hardest hit by the HIV epidemic in Africa, the Caribbean and Asia. The purpose of the present study is to assess President's Emergency Plan for AIDS Relief (PEPFAR) and the success of PEPFAR through analyzing scale up of funding and Number of People on Treatment under PEPFAR FY 2004-FY 2013. Study also includes requirements of submission and the no. of products (NDA and ANDA) approved under President?s emergency expedited review process for better understanding. Finally, PEPFAR alone cannot solve the immense health systems challenges that many countries face, it can set an important example for other donors and affected countries by making the strengthening of health systems through integration with treatment and development programs.

Biography :

Anoop S. Pillai has completed his Bachelors in Pharmacy from Rajiv Gandhi University of Health Sciences, Bangalore at the age of 22 years and currently pursuing Masters of Pharmacy in Pharmaceutical Regulatory Affairs from JSS University, Mysore. He has published 2 papers in reputed journals, 3 poster presentation at national and international conferences and currently is a project trainee in Regulatory Affairs Department at Micro Labs Ltd.